Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MODERN MEDICAL HALLLikely | 1 | ₹2.2 L |
| 2 | Schedule 3 | MEDICAL EQUIPMENT AND ENGG COMPANYLikely | 1 | ₹1,449 |
| 3 | Schedule 4 | Not yet disclosed by govt.Likely | 12 | - |
| 4 | Schedule 5 | Not yet disclosed by govt.Likely | 12 | - |
| 5 | Schedule 7 | Not yet disclosed by govt.Likely | 12 | - |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
20 Jan 2025, 4:00 pmClosed
Eye Drop Moxifloxacin 0 point 5 percent Neutral PH of 6point8 to 7 point 0 osmolality 290 with LPD bott Drop Tainer
Brimonidine 0 point 1 Timolol 0 point 5 percent Eye Drops BAK Free preservative free or purite per oxychlorocomplex based preservative
Sterile 26 G needles single use
Sterile crescent Knife for SICS 2 point 8 mm
Inj HPMC 2 percent with Pre filed syringe PFS for Ophthalmic surgery
Infinity phacoemulsification machine Alcon Fluid management system tubings
Sterile cataract Knife 15 degree side port
Inj Sodium Hyaluronate plus Chondroitin Sulphate 40mg percent 30 mg per ml in pre filled syringe PFS for intra ocular surgery
Inj Sodium Hyaluronate 1 point 4 percent in pre filled syringe PFS for intra ocular surgery
Eye Drop Moxifloxacin Hydrochloride and Dexamethasone phosphate Ophthalmic solution wihdroptainer system with each 10 ml equivalent to Moxifloxacin 5 mg and dexamethasone 1 mg
Hydroxy Propyl Methyl Cellulose HPMC Eye Oint 2 percent BAK Free preservative free or purite per oxychlorocomplex based preservative
Inj Sodium Hyaluroante 1point 4 percent in prefilled syringe
7177991
GEM/2024/B/5643003
Two Packet Bid
Eye Drop Moxifloxacin 0 point 5 percent Neutral PH of
28 days
Punjab; Jalandhar
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹3
80%
Exempted
20 Jan 2025
29 Dec 2024
20 Jan 2025
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Eye Drop Moxifloxacin 0 point 5 percent Neutral PH of 6point8 to 7 point 0 osmolality 290 with LPD bott Drop Tainer | 1,545 | No | JALANDHAR CITY | 28 |
| 2 | Brimonidine 0 point 1 Timolol 0 point 5 percent Eye Drops BAK Free preservative free or purite per oxychlorocomplex based preservative | 750 | No | JALANDHAR CITY | 28 |
| 3 | Sterile 26 G needles single use | 2,100 | No | JALANDHAR CITY | 28 |
| 4 | Sterile crescent Knife for SICS 2 point 8 mm | 600 | No | JALANDHAR CITY | 28 |
| 5 | Inj HPMC 2 percent with Pre filed syringe PFS for Ophthalmic surgery | 750 | No | JALANDHAR CITY | 28 |
| 6 | Infinity phacoemulsification machine Alcon Fluid management system tubings | 120 | No | JALANDHAR CITY | 28 |
| 7 | Sterile cataract Knife 15 degree side port | 600 | No | JALANDHAR CITY | 28 |
| 8 | Inj Sodium Hyaluronate plus Chondroitin Sulphate 40mg percent 30 mg per ml in pre filled syringe PFS for intra ocular surgery | 750 | No | JALANDHAR CITY | 28 |
| 9 | Inj Sodium Hyaluronate 1 point 4 percent in pre filled syringe PFS for intra ocular surgery | 900 | No | Eye Drop Moxifloxacin Hydrochloride JALANDHAR CITY And Dexamethasone | 28 |
| 10 | Eye Drop Moxifloxacin Hydrochloride and Dexamethasone phosphate Ophthalmic solution wihdroptainer system with each 10 ml equivalent to Moxifloxacin 5 mg and dexamethasone 1 mg | 1,662 | No | JALANDHAR CITY | 28 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7177991.pdf
GEM_BID
pic_193_2024-11-24-12-43-01_9909bdde76921923abce644fb28662de.pdf
BOQ
boq_item_sample_file-6_2024-11-24-12-43-01_c11c0b42be2cb6cf9d34f5f39979d031.csv
BOQ
ATC_781b93c9-b7f7-4a8f-b0751732432771380_LP_MHJRC.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .